BioHarvest Sciences Inc. (NASDAQ:BHST) Short Interest Update

BioHarvest Sciences Inc. (NASDAQ:BHST) was the target of a significant increase in short interest in the month of September. As of September 30th, there was short interest totaling 28,700 shares, an increase of 84.0% from the September 15th total of 15,600 shares. Based on an average trading volume of 45,000 shares, the days-to-cover ratio is presently 0.6 days. Currently, 0.2% of the shares of the company are short sold. Currently, 0.2% of the shares of the company are short sold. Based on an average trading volume of 45,000 shares, the days-to-cover ratio is presently 0.6 days.

Wall Street Analyst Weigh In

A number of research firms recently commented on BHST. Weiss Ratings reissued a “sell (e+)” rating on shares of BioHarvest Sciences in a report on Wednesday, October 8th. Wall Street Zen raised shares of BioHarvest Sciences to a “hold” rating in a report on Saturday. Three equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $13.67.

Institutional Trading of BioHarvest Sciences

A hedge fund recently raised its stake in BioHarvest Sciences stock. True North Advisors LLC raised its holdings in BioHarvest Sciences Inc. (NASDAQ:BHST) by 676.1% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 168,013 shares of the company’s stock after purchasing an additional 146,365 shares during the period. True North Advisors LLC owned 1.02% of BioHarvest Sciences worth $1,581,000 at the end of the most recent reporting period.

BioHarvest Sciences Price Performance

Shares of NASDAQ BHST opened at $11.28 on Tuesday. BioHarvest Sciences has a 12-month low of $4.66 and a 12-month high of $12.80. The company has a market capitalization of $185.27 million, a PE ratio of -16.11 and a beta of 0.78. The firm’s 50-day moving average is $9.50 and its two-hundred day moving average is $7.69.

BioHarvest Sciences (NASDAQ:BHST) last announced its quarterly earnings results on Monday, August 11th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by ($0.04). BioHarvest Sciences had a negative net margin of 39.95% and a negative return on equity of 11,357.84%. The business had revenue of $8.52 million during the quarter, compared to analysts’ expectations of $8.53 million. BioHarvest Sciences has set its Q3 2025 guidance at EPS. On average, analysts forecast that BioHarvest Sciences will post -0.8 EPS for the current fiscal year.

About BioHarvest Sciences

BioHarvest Sciences Inc is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications.